DK

Dinesh Kundu

Active Director Partner DIN 07291512
DIN 07291512 First appointment Sep 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since Sep 2015
Shareholding value •••• Premium profile

About Dinesh Kundu

Data last updated:

Dinesh Kundu is a Partner at Rohtak Nuclear Medcare Llp (since 2024) and Director at East Ocyon Bio Private Limited (since 2022). The companies operate in Healthcare, Pharma and Life Sciences. The 2 current companies with reported revenue have a combined latest revenue of ₹6.67 Cr; the largest is Rohtak Nuclear Medcare Llp at ₹6.35 Cr (FY 2025). Earlier, Dinesh Kundu was a Director at Qbd Biosciences Private Limited (2021–2023) and Director at Prozo Integrated Logistics Private Limited (2015–2016) and 2 more.

DIN 07291512
Primary Designation Partner
Industry Healthcare
First Appointment 18 Sep 2015
Oldest Company Age 9 yrs
Largest company Rohtak Nuclear Medcare Llp · ₹6.35 Cr (FY 2025)
Combined revenue ₹6.67 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Partner06 Sep 20242017₹6.35 Cr (FY 2025)Active
East Ocyon Bio Private Limited U24290HR2022PTC102002
Director14 Mar 20222022₹32.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Qbd Biosciences Private Limited U74999HR2017PTC069875
Director02 Sep 20212017₹40.23 Cr (FY 2023)Active
Director18 Sep 20152014₹177 Cr (FY 2025)Active
Director07 Oct 20212021₹14.46 Cr (FY 2024)Active
Partner14 Feb 20202020Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Dinesh Kundu

NameDINCompanyDesignation
Manju09661488Rohtak Nuclear Medcare LlpDesignated Partner
Parveen Kundu07944292Rohtak Nuclear Medcare LlpDesignated Partner
Sajni Devi09661739Rohtak Nuclear Medcare LlpDesignated Partner
Narinder Kumar Mehra09535720East Ocyon Bio Private LimitedDirector
Renu07711725East Ocyon Bio Private LimitedDirector

Directorship timeline

Open interactive timeline →
Xypler Genetech Llp
East Ocyon Bio Private Limited
Rohtak Nuclear Medcare Llp
Qbd Biosciences Private Limited
Premium access

Shareholding and investment profile for Dinesh Kundu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dinesh Kundu

Dinesh Kundu currently holds 2 directorships: Rohtak Nuclear Medcare Llp (Partner, since 06 Sep 2024, revenue ₹6.35 Cr (FY 2025)); East Ocyon Bio Private Limited (Director, since 14 Mar 2022, revenue ₹32.3 Lakh (FY 2025)).

Dinesh Kundu was first appointed on 18 Sep 2015 as Director at Prozo Integrated Logistics Private Limited. The most recent appointment on record is 06 Sep 2024 at Rohtak Nuclear Medcare Llp.

The 2 current companies of Dinesh Kundu that report revenue have a combined latest revenue of ₹6.67 Cr: Rohtak Nuclear Medcare Llp ₹6.35 Cr (FY 2025); East Ocyon Bio Private Limited ₹32.3 Lakh (FY 2025).

Dinesh Kundu held 4 earlier board appointments: Qbd Biosciences Private Limited (Director, 02 Sep 2021 to 31 Mar 2023); Prozo Integrated Logistics Private Limited (Director, 18 Sep 2015 to 09 May 2016); Nuclear Medsystems India Private Limited (Director, 07 Oct 2021 to 01 Sep 2022); Xypler Genetech Llp (Partner, from 14 Feb 2020).

The current boards of Dinesh Kundu's companies include Manju (Rohtak Nuclear Medcare Llp), Parveen Kundu (Rohtak Nuclear Medcare Llp), Sajni Devi (Rohtak Nuclear Medcare Llp), Narinder Kumar Mehra (East Ocyon Bio Private Limited), Renu (East Ocyon Bio Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available